Phase II Study of Neuromuscular Electrical Multisite System on Cardiovascular Effects in Severe Obese Patients (StimobII)
Acute and Medium-term Effects of Neuromuscular Electrical Multisite System (Kneehab®) on Cardiovascular Parameters and Induced Muscle Fatigue in Morbidly Obese Patients: Comparison With the Unidirectional Standard Device
The study was designed to test the following hypotheses:
In patients with severe obesity, a multisite electrostimulation session (m-NMES) will induce higher changes in metabolic, inflammatory and cardiovascular parameters and higher increase in muscle strength during stimulated contractions than conventional unidirectional electrostimulation session (c-NMES).
In patients with severe obesity, a six-weeks m-NMES training program will enhance cardiovascular, metabolic and inflammatory parameters.
調査の概要
詳細な説明
Background: Physical activity is known to reduce cardiovascular risk as far as even minor change in lifestyle could occur. In obesity, physical activity programs remain challenging due to multifactorial causes related to body mass such as shortness of breath, traumatological pain or psychosocial causes. Although neuromuscular electrical stimulation training is presently ignored in the management of obesity, this technique may be appropriate and useful for muscle deconditioning in these patients. Furthermore, direct effects of electrostimulation training program on vascular function have been previously reported in spinal cord injury and chronic heart disease, suggesting that improvement in cardiovascular function may be expected. While a promising new technique of multisite electrical stimulation (the Kneehab® system) has been recently commercialized, few study have investigated the acute effects of electrostimulation on vascular function and not any study report the effects of electrical stimulation in obese patients.
MAIN OUTCOME OF THE ACUTE PHASE STUDY (1st part):To study the effect of multisite electrical stimulation session (m-NMES) on arterial stiffness as compared to conventional unidirectional electrical stimulation session (c-NMES) in patients with severe obesity. Secondary outcomes of the observational study: 1/ To study the effect of m-NMES on endothelial function, blood pressure, systemic inflammation and metabolic status (fasting glucose and insulin) as well as electrically-induced muscle fatigue as compared with c-NMES in patients with morbid obesity. 2/ To study the profile of responders to electrical stimulation according to body composition, 6-minute walking distance, spontaneous physical activity or susceptibility to tolerate electrical stimulation. Response to electrical stimulation will be assessed by an improvement in arterial stiffness after stimulation, if so.
MAIN OUTCOME OF THE INTERVENTIONAL STUDY (2nd part):To study the effect of a multisite electrical stimulation training program (m-NMES) (6 weeks, 30 sessions) on arterial stiffness in patients with severe obesity. Secondary outcomes of the interventional study: To study the effect of m-NMES on endothelial function, blood pressure, systemic inflammation and metabolic status (fasting glucose and insulin) as well as muscle strength, body composition, functional capacity (6-minute walking distance) and spontaneous physical activity, after 15 sessions (3 weeks) and after 30 sessions (6 weeks) of training program. Evaluation of the dose-response to m-NMES training in terms of arterial stiffness and functional capacity.
Expected outcomes: Acute change in arterial stiffness and/or endothelial function is expected after one m-NMES session and/or after c-NMES session. M-NMES session is expected to induce higher changes than c-NMES stimulation session on cardiovascular and muscle parameters. Chronic changes in arterial stiffness and/or endothelial function is expected after 6 weeks of m-NMES training.
研究の種類
入学 (予想される)
段階
- 適用できない
連絡先と場所
研究場所
-
-
-
Grenoble、フランス
- 募集
- Hopital Universitaire
-
コンタクト：
- Jean-Louis Pepin, MD, PhD
- 電話番号：0476765516
- メール：JPepin@chu-grenoble.fr
-
コンタクト：
- Isabelle, Vivodtzev, PhD
- 電話番号：0476510304
- メール：i.vivodtzev@agiradom.com
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Male or female, aged over 18 years
- Morbid obesity (BMI > 35 kg/m²)
- Not included into exercise training program in the year prior to inclusion- Spontaneous physical activity lower than 160 min wk (i.e. < 30 min/d x 5 d/wk).
Additional Inclusion criteria for the interventional study:
- Patients with PWV > 9.3 m / s
Exclusion Criteria:
- Underage- Pregnant or parturient women
- Persons deprived of their liberty for judicial or administrative reasons, person under a legal protection measure (article L1121-8)
- Exclusion period in other studies- Person not affiliated to a social security scheme
- Chronic alcoholism
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：処理
- 割り当て：ランダム化
- 介入モデル：クロスオーバー割り当て
- マスキング：独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
他の：m-NMES first
Multisite electrostimulator first (Visit 1) and conventional electrostimulator then (Visit 2)
|
他の名前：
|
|
他の：c-NMES first
Conventional electrostimulator first (Visit 1) and multisite electrostimulator then (Visit 2)
|
他の名前：
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Delta arterial stiffness
時間枠：Day1 and Day3
|
Change in carotid-femoral Pulse wave velocity (PWV) after NMES sessions
|
Day1 and Day3
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Delta pulse arterial tonus (RH-PAT)
時間枠：Day1 and Day3
|
change in pulse arterial tonometry after NMES sessions
|
Day1 and Day3
|
|
NMES-induced muscle fatigue
時間枠：Day1 and Day3
|
change in maximal voluntary contraction after NMES sessions
|
Day1 and Day3
|
|
Delta blood pressure
時間枠：Day1 and Day3
|
changes in systolic and diastolic blood pressures after NMES sessions
|
Day1 and Day3
|
|
Delta plasmatic biomarkers
時間枠：Day1 and Day3
|
changes in inflammatory and metabolic plasmatic biomarkers after NMES sessions
|
Day1 and Day3
|
|
Body composition
時間枠：Day1, Day21 and Day 42
|
Fat-free mass and fat-free mass indexes assessed by impedancemetry
|
Day1, Day21 and Day 42
|
|
Spontaneous physical activity
時間枠：Day1 and Day 42
|
Number of hours per day of physical activity at 1, 2, 3, 4 or 5 metabolic equivalent(METS),Number of step per day,using a 7-days actigraphy
|
Day1 and Day 42
|
|
Maximal voluntary contraction
時間枠：Day1, Day21 and Day 42
|
Quadriceps peak force
|
Day1, Day21 and Day 42
|
|
Walking distance
時間枠：Day1 and Day 42
|
6-minute-walking test
|
Day1 and Day 42
|
|
Arterial stiffness
時間枠：Day1, Day21 and Day 42
|
Pulse wave velocity (PWV) measurements
|
Day1, Day21 and Day 42
|
|
Pulse artery tone (RH-PAT)
時間枠：Day1, Day21 and Day 42
|
Pulse artery tonometry measurement
|
Day1, Day21 and Day 42
|
|
Plasmatic biomarkers
時間枠：Day1, Day21 and Day 42
|
Inflammatory and metabolic biomarkers
|
Day1, Day21 and Day 42
|
|
Blood pressure
時間枠：Day1, Day21 and Day 42
|
Arterial systolic and diastolic blood pressure
|
Day1, Day21 and Day 42
|
|
Response to m-NMES
時間枠：Day42
|
Delta in current intensity during m-NMES between the first to the last session
|
Day42
|
協力者と研究者
スポンサー
捜査官
- 主任研究者：Jean-Louis Pépin, MD, PhD、Laboratoire EFCR, CHU de Grenoble, 38043, Grenoble, France
研究記録日
主要日程の研究
研究開始
一次修了 (予想される)
研究の完了 (予想される)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (見積もり)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- 12-AGIR-04
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。